Systolic Blood Pressure and Risk of Type 2 Diabetes: A Mendelian Randomization Study (Q38814884)

6 September 2017

0 references

Systolic Blood Pressure and Risk of Type 2 Diabetes: A Mendelian Randomization Study (English)

1 reference

6 September 2017

1 reference

2

1 reference

6 September 2017

7

Veikko Salomaa

1 reference

6 September 2017

3

Danish Saleheen

1 reference

6 September 2017

8

Benjamin F Voight

1 reference

6 September 2017

6

Emmi Tikkanen

1 reference

6 September 2017

Rachael C Aikens

1

1 reference

6 September 2017

Muredach P Reilly

series ordinal

4

1 reference

6 September 2017

Stephen E Epstein

series ordinal

5

1 reference

6 September 2017

language of work or name

English

0 references

publication date

4 October 2016

1 reference

6 September 2017

8

1 reference

inferred from page(s)

published in

Diabetes

1 reference

6 September 2017

66

1 reference

6 September 2017

543-550

1 reference

6 September 2017

2

1 reference

Body mass index relates to blood pressure among adults

6 September 2017

1 reference

12 December 2020

Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial--Blood Pressure Lowering Arm and the relative influence of antihypertensive medication

1 reference

12 December 2020

Mendelian randomisation and causal inference in observational epidemiology

1 reference

12 December 2020

Relationships between body mass index, cardiovascular mortality, and risk factors: a report from the SCORE investigators

1 reference

12 December 2020

MR_predictor: a simulation engine for Mendelian Randomization studies

1 reference

12 December 2020

A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease

1 reference

12 December 2020

MeRP: a high-throughput pipeline for Mendelian randomization analysis

1 reference

12 December 2020

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

1 reference

12 December 2020

Usual Blood Pressure and Risk of New-Onset Diabetes: Evidence From 4.1 Million Adults and a Meta-Analysis of Prospective Studies

1 reference

12 December 2020

Diabetes, hypertension, and cardiovascular disease: an update

1 reference

12 December 2020

Inflammation, insulin resistance, and diabetes--Mendelian randomization using CRP haplotypes points upstream

1 reference

12 December 2020

Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes

1 reference

12 December 2020

Instruments for causal inference: an epidemiologist's dream?

1 reference

12 December 2020

Incident diabetes in clinical trials of antihypertensive drugs.

1 reference

12 December 2020

The predictive effect of body mass index on type 2 diabetes in the Norwegian women and cancer study

1 reference

12 December 2020

Renin-angiotensin system blockers protect pancreatic islets against diet-induced obesity and insulin resistance in mice

1 reference

12 December 2020

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

12 December 2020

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis

1 reference

12 December 2020

Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus

1 reference

12 December 2020

Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis

1 reference

12 December 2020

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study

1 reference

12 December 2020

Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants

1 reference

12 December 2020

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

12 December 2020

Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods

1 reference

12 December 2020

Antihypertensive medications: benefits of blood pressure lowering and hazards of metabolic effects

1 reference

12 December 2020

Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility

1 reference

12 December 2020

Genetic evidence for a normal-weight "metabolically obese" phenotype linking insulin resistance, hypertension, coronary artery disease, and type 2 diabetes

1 reference

12 December 2020

Blood pressure, stroke, and coronary heart disease

1 reference

12 December 2020

Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002.

1 reference

12 December 2020

Cardiovascular risk factor changes in Finland, 1972-1997

1 reference

12 December 2020

Genome-wide association study identifies eight loci associated with blood pressure

1 reference

12 December 2020

Inflammation: the link between insulin resistance, obesity and diabetes

1 reference

12 December 2020

Direct renin inhibition improved insulin resistance and adipose tissue dysfunction in type 2 diabetic KK-A(y) mice

1 reference

12 December 2020

PLINK: a tool set for whole-genome association and population-based linkage analyses

1 reference

12 December 2020

Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study

1 reference

12 December 2020

Insulin resistance in essential hypertension

1 reference

12 December 2020

Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension

1 reference

12 December 2020

Diabetes mellitus and hypertension: a dual threat

1 reference

12 December 2020

Illustrating bias due to conditioning on a collider

1 reference

12 December 2020

Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation

1 reference

12 December 2020

Blood pressure and the risk of developing diabetes in african americans and whites: ARIC, CARDIA, and the framingham heart study

1 reference

12 December 2020

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk

1 reference

12 December 2020

Components of the Metabolic Syndrome and Risk of Type 2 Diabetes

1 reference

12 December 2020

Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes

1 reference

12 December 2020

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

1 reference

12 December 2020

Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator

1 reference

12 December 2020

Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression

1 reference

12 December 2020

Antihypertensive medications and blood sugar: theories and implications

1 reference

12 December 2020

Identifiers

DOI

10.2337/DB16-0868

1 reference

6 September 2017

0 references

1 reference